Anda belum login :: 17 Feb 2025 08:51 WIB
Detail
ArtikelHidradenitis suppurativa is a systemic disease with substantial comorbidity burden: A chart-verified case-control analysis  
Oleh: Shlyankevich, Julia ; Chen, Allison J. ; Kim, Grace E. ; Kimball, Alexandra B.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: JAAD: Journal of the American Academy of Dermatology (keterangan: ada di ClinicalKey) vol. 71 no. 06 (Dec. 2014), page 1144–1150 .
Topik: acne inversa; cardiovascular disease; comorbidities; hidradenitis; hidradenitis suppurativa; lymphoma; metabolic syndrome; obesity; prevalence
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: J15.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelBackground Hidradenitis suppurativa (HS) is a chronic inflammatory disease involving intertriginous skin. Previous epidemiologic studies have been limited by small sample size. Objective We sought to describe the prevalence and comorbidities of HS in a large patient care database. Methods In this retrospective case-control study, we chart-validated all patients within a hospital database who received at least 1 billing code for HS between 1980 and 2013. Verified cases were matched with controls based on age, gender, and race. Prevalences of a priori selected comorbidities were compared between HS and control groups. Results A total of 2292 patients at Massachusetts General Hospital received at least 1 code for HS. A total of 1776 cases had a validated diagnosis of HS, yielding a prevalence of 0.08%. In unadjusted analysis, all comorbidities were diagnosed significantly more in HS compared with control including (in rank order of likelihood): smoking, arthropathies, dyslipidemia, polycystic ovarian syndrome, psychiatric disorders, obesity, drug dependence, hypertension, diabetes, thyroid disease, alcohol dependence, and lymphoma (all P < .01). Limitations Control subjects were not validated for absence of HS and comorbidity validation was not performed for either group. Conclusions Our results highlights the high comorbidity burden of patients with HS compared with matched control subjects.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)